BioAtla saw the highest growth of 2.99% in patent filings in May and 0.66% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of BioAtla‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

BioAtla has been focused on protecting inventions in United States(US) with four publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 60% filings and 33% grants. The United States(US), Australia(AU), China(CN), and Spain(ES) patent Office are among the top ten patent offices where BioAtla is filings its patents. Among the top granted patent authorities, BioAtla has 33% of its grants in United States(US), 33% in Spain(ES) and 33% in Israel(IL).

Regeneron Pharmaceuticals and Amgen could be the strongest competitors for BioAtla

Patents related to nanomedicine and rare diseases lead BioAtla's portfolio

BioAtla has the highest number of patents in nanomedicine followed by, rare diseases and genomics. For nanomedicine, nearly 50% of patents were filed and no patents were granted in Q2 2024.

Cervical cancer related patents lead BioAtla portfolio followed by gastric cancer, and liver cancer

BioAtla has highest number of patents in cervical cancer followed by gastric cancer, liver cancer, kidney cancer (renal cell cancer), and bladder carcinoma.

For comprehensive analysis of BioAtla's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.